DiaCarta
Jump to navigation
Jump to search
| |||
| Diagnostics company | |||
| Industry |
| ||
| Founded | 2011 | ||
| Headquarters | Richmond, California , United States of America | ||
| Website | www | ||
DiaCarta, a molecular and genomics based diagnostics company, was founded in 2011. The company is based in Richmond, California.[1] DiaCarta is developing tests for early detection and monitoring of cancer.[1] DiaCarta's COVID-19 tests have FDA EUA.[2][3]
References
- ↑ 1.0 1.1 "Back to life: Chinese research group revives Richmond manufacturing campus". www.bizjournals.com. Retrieved 2021-03-30.
{{cite web}}: CS1 maint: url-status (link) - ↑ "FDA ranks the performance of 58 molecular coronavirus tests from major developers". FierceBiotech. Retrieved 2021-03-30.
- ↑ "There are 32 authorized coronavirus tests so far—here's how they differ". Fortune. Retrieved 2021-03-30.
External links
This article "DiaCarta" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.